Comparative Effects of Bevacizumab and Aflibercept on VEGF and IGF Signaling in Human Retinal Endothelial Cells Exposed to Hyperoxia and Intermittent Hypoxia

被引：0
|
作者：
Yazdanyar, Amirfarbod [1 ]
Cai, Charles [1 ]
Taimur, Ahmad [1 ]
Shrier, Eric [1 ]
Lazzaro, Douglas R. [1 ]
Valencia, Gloria [1 ]
Aranda, Jacob [1 ]
Beharry, Kay [1 ]
机构：
[1] Suny Downstate Med Ctr, Ophthalmol, Brooklyn, NY 11203 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3358
引用
收藏
页数：3
相关论文
共 50 条
  • [1] IGF-1 and VEGF receptor signaling and interaction in human retinal endothelial cells
    Shaw, LC
    Afzal, A
    Spoerri, PE
    Pan, H
    Grant, MB
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [2] Comparison of Bevacizumab and Aflibercept for Suppression of Angiogenesis in Human Retinal Microvascular Endothelial Cells
    Yazdanyar, Amirfarbod
    Cai, Charles L.
    Aranda, Jacob V.
    Shrier, Eric
    Beharry, Kay D.
    PHARMACEUTICALS, 2023, 16 (07)
  • [3] Dose Response of Bumetanide on Aquaporins and Angiogenesis Biomarkers in Human Retinal Endothelial Cells Exposed to Intermittent Hypoxia
    Guzel, Sibel
    Cai, Charles L.
    Aranda, Jacob V.
    Beharry, Kay D.
    PHARMACEUTICALS, 2021, 14 (10)
  • [4] Effects of Ranibizumab, Bevacizumab, Aflibercept and Ziv-aflibercept on Cultured Human Retinal Muller Cells
    del Carpio, Javier Caceres
    Moustafa, Mohamed Tarek Mohamed
    Ramirez, Claudio A.
    Malik, Deepika
    Kim, Young Gyun
    Thaker, Kunal
    Patel, Tej
    Limb, G. Astrid
    Kenney, Cristina M.
    Kuppermann, Baruch
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [5] Vitamin C Reduces IGF-1 and VEGF Signaling in Retinal Endothelial Cells
    Reynolds, Jonathon C.
    Alger, Tyler J.
    Islam, Nasif
    Manukyan, Varos V.
    Sheppert, Alexander P.
    Wang, Gaofeng
    Sant, David W.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [6] Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture
    Malik, Deepika
    Tarek, Mohamed
    del Carpio, Javier Caceres
    Ramirez, Claudio
    Boyer, David
    Kenney, M. Cristina
    Kuppermann, Baruch D.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 : 11 - 16
  • [7] Comparative effects of dexamethasone and celecoxib on lung vascular endothelial growth factor (VEGF) in newborn rabbits exposed to hyperoxia
    Tambunting, F
    Beharry, KDA
    Ozaki, NK
    Akmal, A
    Valencia, A
    Abrantes, M
    Nishihara, KC
    Modanlou, HD
    PEDIATRIC RESEARCH, 2002, 51 (04) : 352A - 352A
  • [8] Prenatal betamethasone: effects on pulmonary expression of vascular endothelial growth factor (VEGF) in newborn rats exposed to hypoxia and recovered in hyperoxia
    Remesal, A.
    San Feliciano, L.
    Pedraz, C.
    Hernandez, M. J.
    Garcia, R.
    Ludena, D.
    ACTA PAEDIATRICA, 2007, 96 : 96 - 96
  • [9] Reactive Oxygen Species Levels in Human Retinal Pigment Epithelium Cells In vitro to anti-VEGF Agents: Ranibizumab, Bevacizumab, Aflibercept and Ziv-aflibercept
    Lin, Christine
    Malik, Deepika
    Caceres-del-Carpio, Javier
    Tarek, Mohamed
    Costa, Rodrigo Donato
    Boyer, David S.
    Kenney, Cristina M.
    Kuppermann, Baruch
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [10] Effects of aflibercept and bevacizumab treatments under normoxia and hypoxia in human Muller cells (MIO-M1)
    Matsuda, Monique
    Roda, Vinicius Moraes de Paiva
    Silva, Rafael Andre
    Pereira, Graciele Alves
    Monteiro, Mario L. R.
    Marquezini, Monica Valeria
    Hamassaki, Dania E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
12345